Nephrolithiasis in beta thalassemia major patients treated with deferasirox: An advent or an adverse event? A single Greek center experience

Annals of Hematology

Volumn 92, Issue 2, 2013, Pages 263-265

  Efthimia, Vlachaki ^a   Neokleous, Nikolaos ^b   Agapidou, Alexandra ^a   Economou, Marina ^a   Vetsiou, Evaggelia ^a   Teli, Aikaterini ^a   Perifanis, Vasileios ^a  

^a Ippokration Hospital Thessaloniki   (Greece)

^b General Hospital of Limassol   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; HEMOGLOBIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; CALCIUM INTAKE; CHELATION THERAPY; CHILD; DISEASE ASSOCIATION; DRUG SAFETY; ECHOGRAPHY; FEMALE; FLUID INTAKE; GREECE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SPLENECTOMY; THALASSEMIA MAJOR; TRANSFUSION;

ADULT; BENZOATES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; HYPERCALCIURIA; HYPERURICEMIA; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; NEPHROLITHIASIS; POSTOPERATIVE COMPLICATIONS; PYRIDONES; SPLENECTOMY; TRIAZOLES; YOUNG ADULT;

EID: 84872345100     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1558-3     Document Type: Letter

References (10)

1. Ricchi P, Ammirabile M, Costantini S, Di Matola T, Spasiano A, Genna ML, Cinque P, Prossomariti L (2012) Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study. Blood Cells Mol Dis. doi: 10.1016/j.bcmd.2012.05.012
2. Ali D, Mehran K, Moghaddam AG (2008) Comparative evaluation of renal findings in beta-thalassemia major and intermedia. Saudi J Kidney Dis Transpl 19(2):206-209
3. Sumboonnanonda A, Malasit P, Tanphaichitr VS et al (1998) Renal tubular function in beta-thalassemia. Pediatr Nephrol 12:280-283
4. Aldudak B, Karabay Bayazit A, Noyan A et al (2000) Renal function in pediatric patients with beta-thalassemia major. Pediatr Nephrol 15:109-112
5. Koliakos G, Papachristou F, Koussi A et al (2003) Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Haematol 25:105-109
6. Mohkam M, Shamsian BS, Gharib A et al (2008) Early markers of renal dysfunction in patients with beta-thalassemia major. Pediatr Nephrol 23:971-976
7. Smolkin V, Halevy R, Levin C et al (2008) Renal function in children with beta-thalassemia major and thalassemia intermedia. Pediatr Nephrol 23:1847-1851
8. Allon M (1990) Renal abnormalities in sickle cell disease. Arch Intern Med 150:501-504
9. Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, Neufeld EJ, Fung E, Oliveri N, Kirby M, Giardina PJ, Thalassemia Clinical Research Network (2011) Renal dysfunction in patients with thalassaemia. Br J Haematol 153(1):111-117
10. Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:11